To determine their capacity for tumor antigen presentation, IL-15 DCs were loaded by RNA electroporation with the WT1 tumor antigen [30] and examined for their ability to trigger IFN-γ production by a WT1126–134-specific CTL clone. Here, WT1 is linked to neoplasm.